News Release

Co-infection with two common gut pathogens worsens malnutrition in mice

New mouse model could help reveal the impact of gut microbe interactions in malnourished children

Peer-Reviewed Publication


Co-Infection with Two Common Gut Pathogens Worsens Malnutrition in Mice

image: This is histopathology of duodenum in infected mice fed PD diet (20x, H&E, arrows designate trophozoites). view more 

Credit: Bartelt LA, <i>et al</i>. (2017)

Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Malnourished children often face infection with pathogenic microbes that colonize the intestines. These infections disrupt healthy gut microbial communities and harm metabolism and immune system function, worsening malnutrition and impairing children's growth and development. However, the precise effects of co-infection with multiple pathogens in malnourished children are poorly understood.

To gain new insights, Luther Bartelt of the University of North Carolina at Chapel Hill and colleagues developed a new laboratory mouse model of co-infection during malnutrition. They fed weaned mice a protein-deficient diet and infected them with Giardia lamblia and, two weeks later, enteroaggregative Escherichia coli (EAEC) -- two of the pathogens most commonly found in malnourished children.

The researchers then used an array of analytical tools--including stool and urine analysis, flow cytometry, light microscopy, nuclear magnetic resonance spectroscopy, and 16S rRNA analysis -- to observe the wide-ranging effects of this sequential co-infection.

They found that Giardia and EAEC combined to increase weight loss in the young mice. This appeared to be a result of both impaired metabolism and worsened immune system function in the mucosal lining of the mice's intestines. Co-infection also amplified protein breakdown by gut microbes and simultaneously interfered with the ability for the mouse metabolism to adapt to protein deficiency.

These findings and future studies in similar co-infection mouse models could help reveal new insights that cannot be gleaned from single-pathogen studies alone. They could also help inform ongoing long-term studies of malnutrition in children and, ultimately, the development of new treatments or better combinations of existing treatments to restore healthy gut conditions in malnourished children.

"We observed unique inflammatory and metabonomic consequences of Giardia and EAEC infections, no only separately, but also during co-infection," the authors explain. "These findings inform our understanding of similar perturbations seen in malnourished children, and change how we think about mechanisms driving multi-enteropathogen-associated enteropathy."


In your coverage please use this URL to provide access to the freely available article in PLOS Pathogens:

Citation: Bartelt LA, Bolick DT, Mayneris-Perxachs J, Kolling GL, Medlock GL, Zaenker EI, et al. (2017) Cross-modulation of pathogen-specific pathways enhances malnutrition during enteric co-infection with Giardia lamblia and enteroaggregative Escherichia coli. PLoS Pathog 13(7): e1006471.

Funding: This study was supported in part by the National Institutes of Health National Institute of Allergy and Infectious Diseases Grant K08-AI108730 (LAB), U19-AI109776 (RLG) and AI-109591 (SMS) [], National Institute of Diabetes, Digestive, and Kidney Diseases Grant P30-DK034987 (The Center for Gastrointestinal Biology and Disease at the University of North Carolina at Chapel Hill (Microbiome Core and Histology Core)), [], and National Institute of General Medical Sciences #108501 (GLK, GLM, and JP) []. This study was also supported in part by the The Bill and Melinda Gates Foundation Grant OPP-1066140 and OPP 1137923 (RLG) []. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: LAB was a temporary consultant for Lupin Pharmaceuticals, June - December 2015.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.